pH-sensitive lipid nanoparticles for EGF mRNA delivery
Delivery StrategyThe upstream source summary describes a 2026 primary study describing pH-sensitive lipid nanoparticles fabricated by microfluidics to deliver in-vitro-transcribed EGF mRNA for cutaneous wound healing, with sustained local expression, HaCaT proliferation/migration effects, and efficacy in a mouse full-thickness wound model.